Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Solid first half paves way for AMS' growth

This article was originally published in Clinica

Executive Summary

Woundcare specialist Advanced Medical Solutions (AMS) has posted its first ever profitable half-year results, after revenues of £7.9m ($15.9m) - a 22% increase on the same period the previous year - contributed to an overall pre-tax profit of £0.7m. The Cheshire, UK-based firm highlighted four key events as the main drivers behind the positive financial figures: the continued growth of its silver alginate business, the doubling of NHS trusts using its ActivHeal technology to more than 80, the successful US launch of its surgical skin sealant product, and the progression of its LiquiBand tissue adhesive towards US regulatory approval.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel